Indiana University

HomeAbout UsPatient CareEducationResearchLinksTwitterFacebook

Home > Education > Fellowships > The Uro-oncology Fellowship Program


The Uro-oncology Fellowship Program

The Urologic Oncology Fellowship Program at Indiana University began in the 1980ís under the direction of Dr. John Donohue, and later accredited by the Society of Urologic Oncology (SUO) in 2001. Our fellowship is a two-year program comprised of one research year followed by one year of clinical fellowship. Consistent with the mission of the SUO, our goal is to provide a comprehensive training program in clinical genitourinary oncology through advanced surgical training, multidisciplinary didactics, and clinical/translational research endeavors.

During the first year of fellowship, opportunities to participate in clinical, translational and basic science research are available. Areas include protocol development and clinical trial design, collaboration and coordination of translational projects with researchers at Indiana University and Purdue University, and health services and outcomes based study. Basic science research is focused on genetic and translational approaches to the treatment and management of urologic malignancies. Participation in abstract presentation at regional and national meetings and authorship in peer-reviewed publications will be encouraged. The fellow will be responsible for leading a weekly multidisciplinary cancer conference. Opportunities to rotate with our medical oncology and radiation oncology colleagues will be coordinated during this year. Additionally, the fellow will serve as a clinical staff at our county hospital, participating in autonomous resident supervision and teaching. Overall, clinical responsibilities during the first year comprises <10% of the fellows time, with the remaining time protected for research and academic endeavors.

The second year of fellowship is dedicated to clinical time in the operating room. Fellows will participate in a wide array of open and minimally invasive procedures performed under the supervision of our urologic oncology staff. Our clinical experience in complex oncologic and reconstructive surgery is unparalleled, boasting one of the largest surgical experiences in testicular and advanced bladder cancer in the world.

The Urologic Oncology Faculty

  • Michael Koch, M.D. Michael Koch, M.D. John P. Donohue Professor of Urology and Chairman, Department of Urology

    Dr. Koch assumed the position of Chairman of the Department of Urology in early 1998 after Dr. Donohueís retirement. Dr. Kochís clinical and research areas of interest include prostate and bladder carcinoma. The prostate cancer program has undergone rapid growth and includes both a large and rapidly growing surgical experience as well as innovative clinical trials for both early and advanced disease. In 2010, over 300 robotic prostatectomies were performed at our hospital.

  • Timothy Masterson, M.D. Timothy Masterson, M.D. Assistant Professor and Fellowship Program Director

    Dr. Masterson joined our practice in January 2009, becoming fellowship director in 2013. His clinical interest is in urologic oncology. He received his M.D. here at Indiana University School of Medicine before graduating from urology residency at the University of Utah. Then he completed a two year fellowship at Memorial Sloan-Kettering Cancer Center.

  • Richard S. Foster, M.D. Richard S. Foster, M.D. Professor

    Dr. Foster is actively engaged in urologic oncology and general urology. In addition to clinical activity in testis cancer, he directs departmental research activity in germ cell tumors. He is the most experienced surgeon in the surgical treatment of testis cancer in the world today.

  • Richard Bihrle, M.D. Richard Bihrle, M.D. Dr. Norbert M. Welch Sr. and Louise A. Welch Professor of Urology

    Dr. Bihrle specializes in the treatment of adult tumors and reconstructive urologic surgery. Dr. Bihrle was one of the original developers of the Indiana pouch and has a large practice including many patients with intestinal reconstructive procedures. He is acknowledged as an outstanding teacher and clinician.

  • Thomas Gardner, M.D. Thomas Gardner, M.D. Professor

    Dr. Gardner completed his residency at Cornell before going on to complete a two-year post residency fellowship in urologic gene therapy. He joined the faculty in mid-1999 to develop a gene therapy based program in urologic cancer. He has an active practice in oncology and general urology, including minimally invasive surgery.

  • Ronald Boris, M.D. Ronald Boris, M.D. Assistant Professor

    Dr. Boris joined our department in July 2010 after completing a fellowship in urologic oncology at the National Cancer Institute. His area of clinical and research interest includes kidney cancer and other urologic malignancies.

  • Clint Cary, M.D., M.P.H. Clint Cary, M.D., M.P.H. Assistant Professor

    Dr. Cary completed his urology residency here at Indiana University and then went on to complete urologic oncology fellowship at the University of California, San Francisco. In addition, he completed a Master of Public Health degree focused in epidemiology from U.C. Berkeley. His clinical and research interests are in testis, bladder, and prostate cancer.


Current Urologic Oncology Fellows:

Jane Cho, M.D.
Education: New York Medical College
Training: University of California-Irvine

Joseph Jacob, M.D.
Education: Ohio State University
Training: IU School of Medicine

Trainee Publications during Fellowship

Urologic Oncology Fellowship Alumni

Completion Year
Current Status
Jose Pereira Pedrosa, M.D. 2014 Faculty at Hospital Geral de Bonsucesso -- Rio de Janeiro, Brazil
Kevin Rice, M.D. 2013 Faculty at Walther Reed Army Medical Center
Paul Johnston, M.D. 2012 Faculty at Kingston General Hospital in Canada
Mike Risk, M.D. 2011 Faculty at the University of Minnesota
Matei Andreoiu, M.D. 2010 Cooper Clinic, private practice in Arkansas
Yaron Ehrlich, M.D. 2009 Faculty in Tel Aviv Israel
Paul Maroni, M.D. 2007 Faculty at University of Colorado Urologists
Niels Jacobsen, M.D. 2006 Teaching Faculty at Univerisity of Alberta, Aleberat Urology Institute-Canada
Pratik Desai, M.D. 2005 Private practice in Virginia
Mosharafa Asharaf, M.D. 2002 Faculty at Cairo University, Egypt

The Program

The urology oncology fellowship program at the Indiana University School of Medicine has been in existence since the 1980ís and later accredited by the Society of Urologic Oncology (SUO) in 2001.

The fellowship program is two years long. It is divided into one year of clinical urologic oncology training and one year of urologic oncology research. Residents completing an ACGME accredited urology residency program or a similarly accredited international residency program in urology are eligible for application.

The clinical training year provides a broad exposure to routine and complex urologic oncology conditions. The fellowship includes education in the multidisciplinary approach to urologic cancer care, including exposure to radiation oncology, medical oncology, urologic cancer pathology and supportive care.

Surgical training during the clinical year includes adequate exposure to both minimally invasive and open surgical procedures. Although the ratio of minimally invasive and open surgical experience during this training will vary, fellows will be provided with a volume of surgical training in both that will allow the graduating fellow to perform both open and minimally invasive surgery with competence. Adequate exposure to complex open surgical procedures is an important part of this training. Although typical case volumes for our graduating fellows are significantly larger than the minimum requirements, the requirement for each index case involves a minimum of 30 prostatectomy, 25 nephrectomy, 15 cystectomy, and 5 retroperitoneal node dissection cases. The average graduating fellow performs 2-3 times the minimum number of cystectomies required and 10-15 times the minimum number of required retroperitoneal lymph node dissection cases. (see case logs listed in chart below)

Case log numbers from the 8 most recent fellows (Not in any particular order)

Radical prostatectomy
Radical cystectomy, conduit
Radical cystectomy, continent diversion
Pelvic exenteration with diversion
Retroperitoneal lymph node dissection
Radical nephrectomy
Partial nephrectomy
Inguinal Lymph Node Dissection

The research training year consists of a health services track or laboratory research, or may include a combination of both. The research year includes at least 80% protected time for conducting research without clinical responsibilities. The department has robust research databases in the major urologic cancers and can also provide experience working with larger population-based datasets as well. The research training provides the fellow with a valuable educational experience that will result in peer-reviewed publications in urologic cancer journals. Research training also includes instruction in evidence-based medicine, clinical trial design, biostatistics, and grant writing. Fellows also receive education in the basic science and molecular aspects of urologic cancer. Research opportunities may be EITHER in health services research or basic science research although SUO accredited institutions are encouraged to offer both options.

More details of the requirements governed by the SUO are available on the website at

Teaching Staff

  • Michael Koch, M.D., Professor and Chairman
  • Timothy Masterson, M.D., Associate Professor and Program Director
  • Richard Foster, M.D., Professor
  • Thomas Gardner, M.D., Professor
  • Richard Bihrle, M.D., Professor
  • Ronald Boris, M.D., Associate Professor
  • Clint Cary, M.D., M.P.H., Assistant Professor

Should you have any further questions or require any additional information, please donít hesitate to contact me.

Looking forward to meeting you soon!

Timothy Masterson, MD
Associate Professor and Program Director

Alternate Program Contact:

Tina Hedges
Residency/Fellowship Coordinator
IU School of Medicine ~ Department of Urology
535 Barnhill Dr, Suite 420
Indianapolis, IN 46202
Phone: (317) 278-0221
Fax: (317) 278-0499